Corning will manufacture a hand-held, battery-operated device developed by the FDA to identify fake or substandard malaria drugs. The device will be tested first in Ghana, then in other areas where malaria rates are high and counterfeit drugs are common. The agency said it hopes to use the device more broadly in the U.S.

Related Summaries